ClinVar Miner

Submissions for variant NM_000038.6(APC):c.422+2T>C (rs879254169)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000411017 SCV000489058 likely pathogenic Familial adenomatous polyposis 1 2016-08-09 criteria provided, single submitter clinical testing
GeneDx RCV000235994 SCV000293703 likely pathogenic not provided 2015-12-17 criteria provided, single submitter clinical testing This variant is denoted APC c.422+2T>C or IVS4+2T>C and consists of a T>C nucleotide substitution at the +2 position of intron 4 of the APC gene. This variant destroys a canonical splice donor site and is predicted to cause abnormal gene splicing, leading to either an abnormal message that is subject to nonsense-mediated mRNA decay or to an abnormal protein product. This variant has been identified in at least 2 individuals being evaluated for Familial Adenomatous Polyposis (FAP) (Lagarde 2010, Kerr 2013). Based on the currently available information, we consider APC c.422+2T>C to be a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.